China Steel Chemical Corporation AI Stock Analysis
China Steel Chemical Corporation (1723) AI Stock Analysis
China Steel Chemical Corporation
(TWSE:1723)
China Steel Chemical scores moderately well, anchored by a strong financial profile: low leverage, a growing equity base and reliable cash generation that stayed positive throughout the downcycle provide meaningful downside protection, while revenue, margins and profits have begun recovering from the cyclical trough. Offsetting this is weak technical positioning — the stock trades below all major moving averages with negative MACD momentum, albeit at deeply oversold readings that could support a near-term bounce. Valuation is a secondary drag, with a P/E of 20.2 looking full for a cyclical whose earnings remain well below 2022–2023 peaks and are partly supported by non-operating income, though a 2.6% dividend yield adds some income appeal. Earnings call and corporate event data were unavailable and excluded, with their weight redistributed across the remaining components.
China Steel Chemical Corporation (1723) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 16.25B
- Dividend Yield
- 2.65%
- Average Volume (3M)
- 607.05K
- Price to Earnings (P/E)
- 19.9
- Beta (1Y)
- 0.21
- Revenue Growth
- 7.82%
- EPS Growth
- 10.83%
- Country
- TW
- Employees
- 1,489
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
China Steel Chemical Corporation Business Overview & Revenue Model
Company Description
China Steel Chemical Corporation, together with its subsidiaries, engages in the production, processing, and sale of coal tar distillation, light oil, coke, and refined carbon material products in Taiwan, China, Australia, and internationally. The co...
China Steel Chemical Corporation Financial Statement Overview
Summary
A conservatively financed chemicals producer emerging from a cyclical trough. The balance sheet is the standout (score 80): equity of NT$8.27 billion funds roughly two-thirds of assets, debt-to-equity is a low 0.34, and book value has grown steadily even through the downturn — though ROE of 10.1% is still well below the 21% peak. The income statement (score 63) is improving, with TTM revenue up about 12% to NT$6.74 billion, gross margin up to 19.2% and net income up to NT$815 million, but profits remain far below 2022–2023 levels and are partly supported by non-operating income (net income exceeds EBIT). Cash flow (score 70) is dependable, with operating cash flow of NT$1.33 billion comfortably exceeding net income and free cash flow of NT$603 million up about 28%, though heavy capital spending limits free cash flow conversion to roughly 45% of profit.
Income Statement
63PositiveBalance Sheet
80PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.74B | 5.82B | 7.65B | 8.32B | 10.46B | 7.98B |
| Gross Profit | 1.29B | 982.82M | 1.82B | 2.10B | 2.37B | 1.61B |
| EBITDA | 1.13B | 925.57M | 1.91B | 2.22B | 2.25B | 1.67B |
| Net Income | 814.91M | 615.82M | 1.21B | 1.44B | 1.70B | 1.10B |
Balance Sheet | ||||||
| Total Assets | 12.07B | 11.44B | 11.47B | 11.38B | 11.21B | 11.73B |
| Cash, Cash Equivalents and Short-Term Investments | 1.57B | 1.82B | 1.78B | 1.83B | 2.08B | 1.67B |
| Total Debt | 2.78B | 2.86B | 2.31B | 2.02B | 1.85B | 2.64B |
| Total Liabilities | 3.80B | 3.62B | 3.25B | 3.17B | 3.13B | 4.11B |
| Stockholders Equity | 8.27B | 7.82B | 8.22B | 8.21B | 7.99B | 7.35B |
Cash Flow | ||||||
| Free Cash Flow | 602.95M | 497.24M | 603.95M | 558.81M | 2.38B | 1.17B |
| Operating Cash Flow | 1.33B | 1.03B | 1.46B | 1.11B | 2.63B | 1.38B |
| Investing Cash Flow | -735.92M | -482.65M | -801.16M | -358.65M | 18.05M | -127.41M |
| Financing Cash Flow | -505.61M | -513.42M | -686.54M | -1.14B | -1.76B | -1.61B |
China Steel Chemical Corporation Peers Comparison
Overall Rating
TW:172363Neutral
TW:171460Neutral
TW:170957Neutral
TW:171144Neutral
TW:131340Underperform
TW:171039Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | TWD 16.23B | 19.91 | ― | 2.65% | 7.82% | 10.83% | |
| 60Neutral | TWD 15.46B | 13.39 | ― | 1.14% | 36.28% | 243.10% | |
| 57Neutral | TWD 21.75B | 22.80 | ― | 2.19% | -3.01% | 82.22% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 44Neutral | TWD 21.66B | 266.83 | ― | 0.80% | -2.22% | 33.13% | |
| 40Underperform | TWD 15.17B | 78.33 | ― | 0.85% | -0.93% | ― | |
| 39Underperform | TWD 13.95B | -19.17 | ― | ― | -13.29% | -157.29% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1723 | China Steel Chemical Corporation | 69.90 | -8.21 | -10.51% | |
| TW:1313 | UPC Technology Corporation | 11.75 | 1.34 | 12.88% | |
| TW:1709 | Formosan Union Chemical Corp. | 45.60 | 29.24 | 178.80% | |
| TW:1710 | Oriental Union Chemical Corp. | 16.00 | 3.25 | 25.49% | |
| TW:1711 | Everlight Chemical Industrial Corporation | 36.85 | 17.91 | 94.59% | |
| TW:1714 | Ho Tung Chemical Corp. | 15.80 | 7.45 | 89.24% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
